Enfusion, Inc. (ENFN)

NYSE: ENFN · IEX Real-Time Price · USD
9.25
+0.02 (0.22%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Total Valuation

Enfusion has a market cap or net worth of $817.83 million. The enterprise value is $797.66 million.

Market Cap 817.83M
Enterprise Value 797.66M

Important Dates

The last earnings date was Tuesday, March 12, 2024, before market open.

Earnings Date Mar 12, 2024
Ex-Dividend Date n/a

Share Statistics

Enfusion has 89.87 million shares outstanding. The number of shares has increased by 51.57% in one year.

Shares Outstanding 89.87M
Shares Change (YoY) +51.57%
Shares Change (QoQ) -0.21%
Owned by Insiders (%) 8.53%
Owned by Institutions (%) 95.62%
Float 39.60M

Valuation Ratios

The trailing PE ratio is 132.14 and the forward PE ratio is 39.43.

PE Ratio 132.14
Forward PE 39.43
PS Ratio 4.69
Forward PS 3.92
PB Ratio 15.24
P/FCF Ratio 51.23
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 33.97, with an EV/FCF ratio of 49.97.

EV / Earnings 132.39
EV / Sales 4.57
EV / EBITDA 33.97
EV / EBIT 120.58
EV / FCF 49.97

Financial Position

The company has a current ratio of 3.44, with a Debt / Equity ratio of 0.29.

Current Ratio 3.44
Quick Ratio 3.14
Debt / Equity 0.29
Debt / EBITDA 0.66
Debt / FCF 0.97
Interest Coverage -4.03

Financial Efficiency

Return on equity (ROE) is 11.10% and return on invested capital (ROIC) is 12.62%.

Return on Equity (ROE) 11.10%
Return on Assets (ROA) 5.70%
Return on Capital (ROIC) 12.62%
Revenue Per Employee $158,380
Profits Per Employee $5,467
Employee Count 1,102
Asset Turnover 1.64
Inventory Turnover n/a

Taxes

In the past 12 months, Enfusion has paid $2.23 million in taxes.

Income Tax 2.23M
Effective Tax Rate 27.02%

Stock Price Statistics

The stock price has decreased by -8.34% in the last 52 weeks. The beta is 0.99, so Enfusion's price volatility has been similar to the market average.

Beta (1Y) 0.99
52-Week Price Change -8.34%
50-Day Moving Average 8.75
200-Day Moving Average 9.25
Relative Strength Index (RSI) 56.86
Average Volume (30 Days) 409,845

Short Selling Information

The latest short interest is 1.67 million, so 1.86% of the outstanding shares have been sold short.

Short Interest 1.67M
Short Previous Month 1.70M
Short % of Shares Out 1.86%
Short % of Float 4.22%
Short Ratio (days to cover) 4.59

Income Statement

In the last 12 months, Enfusion had revenue of $174.54 million and earned $6.03 million in profits. Earnings per share was $0.07.

Revenue 174.54M
Gross Profit 116.89M
Operating Income 11.95M
Pretax Income 8.26M
Net Income 6.03M
EBITDA 23.48M
EBIT 6.62M
Earnings Per Share (EPS) $0.07
Full Income Statement

Balance Sheet

The company has $35.60 million in cash and $15.44 million in debt, giving a net cash position of $20.17 million or $0.22 per share.

Cash & Cash Equivalents 35.60M
Total Debt 15.44M
Net Cash 20.17M
Net Cash Per Share $0.22
Equity / Book Value 53.67M
Book Value Per Share 0.60
Working Capital 49.54M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $25.63 million and capital expenditures -$9.67 million, giving a free cash flow of $15.96 million.

Operating Cash Flow 25.63M
Capital Expenditures -9.67M
Free Cash Flow 15.96M
FCF Per Share $0.18
Full Cash Flow Statement

Margins

Gross margin is 66.97%, with operating and profit margins of 6.85% and 3.45%.

Gross Margin 66.97%
Operating Margin 6.85%
Pretax Margin 4.73%
Profit Margin 3.45%
EBITDA Margin 13.46%
EBIT Margin 3.79%
FCF Margin 9.15%

Dividends & Yields

Enfusion does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -51.57%
Shareholder Yield -51.57%
Earnings Yield 0.74%
FCF Yield 1.95%

Analyst Forecast

The average price target for Enfusion is $9.33, which is 0.86% higher than the current price. The consensus rating is "Sell".

Price Target $9.33
Price Target Difference 0.86%
Analyst Consensus Sell
Analyst Count 6
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Enfusion has an Altman Z-Score of 15.71 and a Piotroski F-Score of 5.

Altman Z-Score 15.71
Piotroski F-Score 5